Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$85.57+2.09 (+2.50%)
Close on Nov 18, 2026Market cap $35.36BP/E 14.1Yield 2.37%
Zoetis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Zoetis's revenue for the twelve months ending Jun 30, 2026 was $9.52B, up 1.5% year over year. For fiscal 2025 it was $9.47B, up 2.3% from the year before. Over ten years it grew 7.1% a year on average. The highest annual figure on record is $9.47B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.47B | +2.3% |
| FY2024 | Dec 31, 2024 | $9.26B | +8.3% |
| FY2023 | Dec 31, 2023 | $8.54B | +5.7% |
| FY2022 | Dec 31, 2022 | $8.08B | +3.9% |
| FY2021 | Dec 31, 2021 | $7.78B | +16.5% |
| FY2020 | Dec 31, 2020 | $6.68B | +6.6% |
| FY2019 | Dec 31, 2019 | $6.26B | +7.5% |
| FY2018 | Dec 31, 2018 | $5.83B | +9.8% |
| FY2017 | Dec 31, 2017 | $5.31B | +8.6% |
| FY2016 | Dec 31, 2016 | $4.89B | +2.6% |
| FY2015 | Dec 31, 2015 | $4.77B | -0.4% |
| FY2014 | Dec 31, 2014 | $4.79B | +4.9% |
| FY2013 | Dec 31, 2013 | $4.56B | +5.2% |
| FY2012 | Dec 31, 2012 | $4.34B | +2.4% |
| FY2011 | Dec 31, 2011 | $4.23B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.47B | -0.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.26B | +2.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.39B | +3.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.40B | +0.5% |
| Q2 FY2025 | Jun 30, 2025 | $2.47B | +4.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.20B | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.32B | +4.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.39B | +11.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.36B | +8.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.19B | +9.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.21B | +8.5% |
| Q3 FY2023 | Sep 30, 2023 | $2.15B | +7.4% |
| Q2 FY2023 | Jun 30, 2023 | $2.18B | +6.2% |
| Q1 FY2023 | Mar 31, 2023 | $2.00B | +0.7% |
| Q4 FY2022 | Dec 31, 2022 | $2.04B | +3.7% |
| Q3 FY2022 | Sep 30, 2022 | $2.00B | +0.6% |
| Q2 FY2022 | Jun 30, 2022 | $2.05B | +5.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.99B | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.97B | +8.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.99B | +11.4% |
| Q2 FY2021 | Jun 30, 2021 | $1.95B | +25.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.87B | +22.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.81B | +7.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.79B | +12.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.55B | +0.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.53B | +5.4% |
| Q4 FY2019 | Dec 31, 2019 | $1.67B | +7.0% |
| Q3 FY2019 | Sep 30, 2019 | $1.58B | +7.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.55B | +9.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.46B | +6.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.56B | +7.1% |
| Q3 FY2018 | Sep 30, 2018 | $1.48B | +9.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.42B | +11.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.37B | +11.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.46B | +14.3% |
| Q3 FY2017 | Oct 1, 2017 | $1.35B | +8.5% |
| Q2 FY2017 | Jul 2, 2017 | $1.27B | – |
| Q1 FY2017 | Apr 2, 2017 | $1.23B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.28B | – |
| Q3 FY2016 | Oct 2, 2016 | $1.24B | – |
See a number that looks wrong?